Compugen (CGEN) Cash & Equivalents (2009 - 2026)
Compugen (CGEN) reported Cash & Equivalents of $10.28 million for Q2 2026, up 59.0% from $6.47 million a year earlier but down 17.3% from the prior quarter.
Powered by 
Analysis
Compugen (CGEN) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Compugen posted Cash & Equivalents of $90.6 million, up 397.0% from FY2024.
- Cash & Equivalents has increased for four consecutive years, with a five-year compound annual growth rate of 55.9% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $18.23 million in FY2024 (+27.9%), $14.26 million in FY2023 (+24.8%), $11.42 million in FY2022 (+46.2%) and $7.81 million in FY2021 (-20.6%).
- Five-year quarterly Cash & Equivalents spans a low of $6.47 million in Q2 2025 and a high of $90.6 million in Q4 2025.
- Year over year, Cash & Equivalents gained in four of the last six quarters, with growth averaging 70.4%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2025 (growth of 397.0%); the low point was Q2 2025 (a decline of 53.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.44 million (Q1 2026), $90.6 million (Q4 2025) and $7.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Compugen | 221.25 Mn | -151.83 Mn | -92,000.00 | 10.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.28 Mn |
| Mar 31, 2026 | 12.44 Mn |
| Dec 31, 2025 | 90.60 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 14.58 Mn |
| Dec 31, 2024 | 18.23 Mn |
| Sep 30, 2024 | 7.22 Mn |
| Jun 30, 2024 | 13.91 Mn |
| Dec 31, 2023 | 13.89 Mn |
| Jun 30, 2023 | 17.69 Mn |
| Dec 31, 2022 | 11.06 Mn |
| Jun 30, 2022 | 8.51 Mn |
| Dec 31, 2021 | 7.80 Mn |
| Jun 30, 2021 | 8.53 Mn |
| Dec 31, 2020 | 7.14 Mn |
| Jun 30, 2020 | 13.11 Mn |
| Dec 31, 2019 | 9.19 Mn |
| Jun 30, 2019 | 6.47 Mn |
| Dec 31, 2018 | 26.52 Mn |
API Access
Compugen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();